leadf
logo-loader
RNS
viewCello Health PLC

AIM - Cancellation - Cello Health PLC

RNS Number : 8170V
AIM
12 August 2020
 

NOTICE

 

12/08/2020 - 7:00am

 

NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM - XLON

 

At the request of the Company the following securities have been cancelled from trading on AIM with effect from the time and date of this notice.

 

CELLO HEALTH PLC

2138004TZYGZLWQP7N64

 

ORDINARY SHARES OF 10P EACH, FULLY PAID

(B031076)(GB00B0310763)

CELO HEAL/PAR VTG FPD 0.1

 

If you have any queries or require further information, please contact the company's nominated adviser on +44 (0)20 7397 8900.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
AMOFLFIFTVILLII

Quick facts: Cello Health PLC

Price: -

Market: AIM
Market Cap: -
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Cello Group hails the impact of a “vibrant” US on the company’s performance

Chief executive of Cello Group (LON:CLL) Mark Scott spoke to Proactive’s Charlotte Kan in the wake of an upbeat trading update from healthcare and strategic consumer marketing specialist. The research and communications operations both performed well, but there was a common theme to update...

on 05/11/2016

2 min read